Question.2747 - This assignment focuses on treatment for schizophrenia, and it assesses ULO 4.4. Instructions Review the DSM-5 criteria for schizophrenia (a good resource is this Cleveland Clinic web page (https://my.clevelandclinic.org/health/diseases/4568-schizophrenia) ). Then, complete the following: Identify and describe two pharmaceutical and three alternative treatments for schizophrenia. Describe each treatment and what is known about the effectiveness and access (such as cost, time commitment, side effects, etc.). Formatting Expectations Use APA guidelines for this assignment (12-point font, 1-inch margins, double spaced). A good resource is OWL (https://owl.purdue.edu/index.html) or Averett’s Writing Center. The content, or body, of your paper should be two pages. All sources should be referenced. Additional resources may include your textbook, other readings or videos, and study materials.
Answer Below:
IntroductionSchizophrenia xx a xxxxxx disorder xxxxx disrupts xxx functioning xx the xxxxx The xxxxxx has xxxxxxxxxxx the xxxxxxxxxx used xx the xxxxxxx to xxxx the xxxxxxxx suffering xxxx the xxxxxxxx It xxx also xxxxxxxxx the xxxxxxxxxxxxxx and xxxxxxxxxxx treatments xx help xxx people xxx are xxxxxxxx Discussion xxx pharmaceutical xxx three xxxxxxxxxxx treatments xxx schizophrenia xxxxxxxxxxxxx is x highly xxxxxxxxx disorder xxx a xxxxx amount xx people xxxx recovered xxxx it xx well xxx pharmaceutical xxxxxxxxxx for xxxxxxxxxxxxx are xx follows xxxxxxxxxxxxx MedicationsAntipsychotic xxxxx are xxxx to xxxxx schizophrenia xxxxx is x condition xxxxxxx to xxxxxxxxx For xxxxxxx a xxxxxx suffering xxxx delusion xxx hallucinations xxxxxx a xxxxxx disassociation xxxx reality xxxxxxxxxxxxx basically xxxxxx the xxxxxxxxx which xxxxxxx the xxx A xxx D xxx mesolimbic xxxxxxxxxxxx neurotransmission xxxxxxxxx Some xxxxxxxx of xxxxxxxxxxxxx drugs xxx Chlorpromazine xxxxxxxxx Fluphenazine xxxxxxxx Haloperidol xxxxxx Perphenazine xxxxxxxx Thioridazine xxxxxxxx etc xxxxxxxxxxxxx and xxxxxx to xxxxxxxxxxxxx medications xxx drugs xxxx the xxxxxxxx with xxxxx psychosis xx clear xxx confusion xxx calm xxx mind xxxxxx four xx six xxxxx With xxx help xx medications xxxxxxxx control xxx symptoms xxxxxxx these xxxxxxxxxxx do xxx cure xxx anti-psychosis xxxxxxxxxxx are xxxxxxxxxx on x long-term xxxxx for xxx prevention xx relapses xxx amelioration xx the xxxxxxx symptoms xxxxxxxxxxxxx drugs xxx costly xxxxxxx of xxx brand xxxx that xx involved xx it xxxxx in xxxxxxxxxx the xxxxxxxx of xxxxxxx for xxx research xx make xx effective xxx safe xxxx of xxx side xxxxxxx of xxx antipsychotic xxxxx are xxxxxxx vision xxx dry xxxxx fluid xxxxxxxxx etc xxxxxxxxxxxxxx MedicationsThe xxxxxxxxxxx for xxxxxxxxxxxxxxx can xx used xxx the xxxxxxxxx of xxxxxxxxxxxxx in xxxxxxxx In xxxxxx clinical xxxxxxxx the xxxxxxxxx treatment xxx schizophrenia xx monopharmacy xxxx antidepressants xxx antipsychotics xxxxxxxxx et xx Moreover xxxxxxxxxxxxxxx block xxx monoamine xxxxxxxx and xxx to xxxxxxxx monoaminergic xxxxxxxxxxxxxxxxx which xxx help xxxxxxxx with xxxxxxxx of xxxxxxxxxx in xxxxxxxxxxxxx Some xx the xxxxxxxx of xxxxxxxxxxxxxxx used xxx schizophrenic xxxxxxxx are xxxxxxxxxx Celexa xxxxxxxxxx Prozac xxxxxxxxxx Paxil xxxxxx Sertraline xxxxxx Escitalopram xxxxxxx etc xxxxxxxxxxxxx and xxxxxx to xxxxxxxxxxxxxx MedicationsAntidepressants xxxxxx in xxx they xxxx the xxxx of xxxxxxxxxxx used xxxxxxxx and xxxx These xxxxxxx mainly xxxxxxxxx the xxxx of xxxx drug xxxxxxx the xxxxxxx medication xxxxx about x per xxxxx For x significant xxxxxxxx antidepressants xxxxx take xxx or xxxx weeks xxx there xx much xxxxxx process xx the xxxxxx of xxx antidepressant xxx to xx titrated xxxxx et xx Some xx the xxxxxxxxxxxxxxx are xxxxxxxxxxxxxx confusion xxxxxxxxxx in xxxxxxxxx etc xxxxxxxxxxx treatment xxx schizophreniaCognitive xxxxxxxxxx therapy xx one xx the xxxx structured xxxx therapy xxxxx can xxxx patients xxxxxxxxx from xxxxxxxxxxxxx to xxxxxx their xxxxxxxx better xxxxxxxxx behavioral xxxxxxx has x larger xxxxxx on xxxxxx cases xx harmful xxxxxxxxxx with xxxxxxxx hallucinations xxx symptoms xxxxxxx to xxxxxxxxx Jauhar xx al xxxxxxxxxxxxx and xxxxxx of xxxxxxxxx Behavioral xxxxxxxxxxxxxx is xx expensive xxxxxxx as xx covers xxx time xxxxx with xxx therapist xxxxx examining xxx patient xxxx therapy xxxxx improve xxx quality xx life xxx helps xxxxxxxx address xxxxxxxx problems xx average xxxxxxx costs xxxxxxx With xxxxxxxxx it xxx be xxxxxxx Therapy xxxxx longer xx it xx done xx an xxxxxxxxxx basis xxx will xxxx and xxxxxxxxxxx or xxxxxx sessions xxxxx will xxxx to xxxxxxx Therapy xx an xxxxxxxxx method xxx patients xxxx schizophrenia xxxxxxx for xxxxxxxx with xxxxxxx mental xxxxxx issues xxxxxxxxx might xx a xxxxxxxxx Electroconvulsive xxxxxxx is xxxx for xxx patients xx schizophrenia xxxxx a xxxx electrical xxxxxxx to xxxxx a xxxxxxx It xxxxx in xxxxxxxxxx discomfort xx using xxx electrical xxxxxxxxx safely xxx primary xxxx of xxxxxxxxxxxxxxxxx therapy xxx schizophrenic xxxxxxxx is xx focus xx the xxxxxxx of xxxxxxxxx functions xxx efficacy xxx role xx neuroimaging xxxxxxxxxx and xxx role xx ECT xxxxxxxxxxx Ali xx al xxxxxxxxxxxxx and xxxxxx to xxxxxxxxxxxxxxxxx therapy xx the xx the xxx cost xxxxxx from xx making xx costly xxxx annual xxxxxxx of xx more xxxx of xxx serious xxxx effects xx ECT xxx confusion xxxxxxxx slight xxxxxx loss xxx fatigue xxxxx symptoms xxx last xxx several xxxxx and xxxxx are xxxxxxx risks xxxxxxxx with xxx effectively xxxxxxx disorders xxxxxxxxx enhancement xxxxxxx CET xx used xxx patients xx recognize xxxxxxxx or xxxxxx cues xxx improve xxxxx memory xxxxxxx to xxxxxxxx their xxxxxxxx and xxxxxx The xxx therapy xx beneficial xx it xxxxxx the xxxxxxxx with xxx help xx group xxxxxxxx and xxxxx training xxxxxxxxxxxxx and xxxxxx to xxxx complete xxxxxx cognitive xxxxxxxxxxx intervention xx required xxx cognitive xxxxxxxxxxx therapy xx improve xxx functioning xxx cognition xx schizophrenia xxxxxxxx The xxxx of xxx is xxxxxxxxx on xxx location xxxxxxxx and xxxxxxxxx of xxx service xxxxxxxx Moreover xxxxxxxxxxx therapy xx used xx improve xxxxxxxxx functions xxxxxxx some xx the xxxx effects xx the xxxxxxx include xxxxxxx in xxxx fatigue xxx increased xxxxxxxxx Conclusion xxxxx are xxxxxxxxx methods xx treat xxx psych xxx condition xx schizophrenia xxxxx methods xxxx the xxxxxxxx with xxx disorder xx improve xxxxx cognitive xxxxxxxxxxx It xxx be xxxxxxxxx from xxx report xxxx there xxx different xxxx of xxxxxxxx schizophrenia xxxxx include xxxxxxxxxxxxx drugs xxx antidepressants xxxx the xxxx of xxxxxxxxx behavioral xxxxxxx Cognitive xxxxxxxxxxx therapy xxx and xxxxxxxxxxxxxxxxx therapy xxxxx treatments xxxx the xxxxxxxx improve xxxxx lives xxxxxxxxxxxxx S x Mathur x Malhotra x K xxxxx R x Electroconvulsive xxxxxxx and xxxxxxxxxxxxx a xxxxxxxxxx review xxxxxxx Psychiatry x Hashimoto x Yasui-Furukori x Hasegawa x Ishikawa x Numata x Hori x Hashimoto x Characteristics xx discharge xxxxxxxxxxxxx for xxxxxxxx with xxxxxxxxxxxxx or xxxxx depressive xxxxxxxx real-world xxxxxxxx from xxx Effectiveness xx Guidelines xxx Dissemination xxx Education xxxxxx psychiatric xxxxxxxxx project xxxxx Journal xx Psychiatry xxxxxx S xxxx K x McKenna x J xxx for xxxxxxxxxxxxx a xxxxxxxx viewpoint xxxxxxxxxxxxx medicine x Malhi x S xxxx E xxxxxx G xxxxxxxx A xxx delay xx response xx antidepressant xxxxxxx A xxxxxx of xxxxxxxxxxx Australian xxx Zealand xxxxxxx of xxxxxxxxxx -More Articles From Psychology
.ico)
.ico)
.ico)
.ico)
